Welcome to the Dr Reddys Stock Liveblog, your ultimate source for real-time updates and analysis of one of the most prominent ...
Dr. Reddy's Lab is poised to witness crosswinds from a drop in revenue from the patent expiration of Revlimid and increased ...
Dr. Reddy's Laboratories Ltd. closed 15.86% below its 52-week high of 1,420.20 rupees, which the company reached on August 21st.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback